Explore

Trendline Trendline
Faruqi Faruqi, LLP Alerts Immutep Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Immutep Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Immutep Investors of Securities Class Action Deadline
Trendline Trendline
Faruqi Faruqi, LLP Alerts Immutep Investors of Class Action Deadline

Faruqi Faruqi, LLP Alerts Immutep Investors of Class Action Deadline

Faruqi Faruqi, LLP Alerts Immutep Investors of Class Action Deadline
Trendline Trendline
Faruqi Faruqi, LLP Alerts Immutep Investors of Class Action Deadline Following Trial Discontinuation

Faruqi Faruqi, LLP Alerts Immutep Investors of Class Action Deadline Following Trial Discontinuation

Faruqi Faruqi, LLP Alerts Immutep Investors of Class Action Deadline Following Trial Discontinuation
Trendline Trendline
Faruqi Faruqi, LLP Alerts Gossamer Bio Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Gossamer Bio Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Gossamer Bio Investors of Securities Class Action Deadline
Trendline Trendline
Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep for Securities Violations

Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep for Securities Violations

Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep for Securities Violations
Trendline Trendline
Faruqi Faruqi, LLP Urges Globant Investors to Consider Legal Action Amid Securities Class Action

Faruqi Faruqi, LLP Urges Globant Investors to Consider Legal Action Amid Securities Class Action

Faruqi Faruqi, LLP Urges Globant Investors to Consider Legal Action Amid Securities Class Action
Trendline Trendline
Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations

Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations

Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations
Trendline Trendline
Faruqi Faruqi, LLP Investigates Gossamer Bio for Securities Violations Amidst Stock Plunge

Faruqi Faruqi, LLP Investigates Gossamer Bio for Securities Violations Amidst Stock Plunge

Faruqi Faruqi, LLP Investigates Gossamer Bio for Securities Violations Amidst Stock Plunge
Trendline Trendline
Entrada Therapeutics Faces Fraud Investigation Over Misleading Investor Statements

Entrada Therapeutics Faces Fraud Investigation Over Misleading Investor Statements

Entrada Therapeutics Faces Fraud Investigation Over Misleading Investor Statements
Trendline Trendline
Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development

Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development

Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development
Trendline Trendline
Marker Therapeutics Reports Q1 2026 Financial Results with Reduced Losses

Marker Therapeutics Reports Q1 2026 Financial Results with Reduced Losses

Marker Therapeutics Reports Q1 2026 Financial Results with Reduced Losses
Trendline Trendline
Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase

Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase

Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase